Expression analysis and study of the KLK15 mRNA splice variants in prostate cancer and benign prostatic hyperplasia

Cancer Science

Volumn 101, Issue 3, 2010, Pages 693-699

  Mavridis, Konstantinos ^a   Avgeris, Margaritis ^a   Koutalellis, Georgios ^b   Stravodimos, Konstantinos ^b   Scorilas, Andreas ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; KALLIKREIN; KALLIKREIN 15; MESSENGER RNA; UNCLASSIFIED DRUG;

ADULT; AGED; ALTERNATIVE RNA SPLICING; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENE FUNCTION; GENE OVEREXPRESSION; HOUSEKEEPING GENE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; REVERSE TRANSCRIPTION; RNA ISOLATION;

AGED; HUMANS; KALLIKREINS; LOGISTIC MODELS; MALE; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; RNA SPLICING;

EID: 77949610036     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2009.01450.x     Document Type: Article

References (37)

1. Hsing AW, Chokkalingam AP. Prostate cancer epidemiology. Front Biosci 2006, 11:1388-413.
2. Rubin MA, De Marzo AM. Molecular genetics of human prostate cancer. Mod Pathol 2004, 17:380-8.
3. Dehm SM, Tindall DJ. Molecular regulation of androgen action in prostate cancer. J Cell Biochem 2006, 99:333-44.
4. Tomlins SA, Rubin MA, Chinnaiyan AM. Integrative biology of prostate cancer progression. Annu Rev Pathol 2006, 1:243-71.
5. Shand RL, Gelmann EP. Molecular biology of prostate-cancer pathogenesis. Curr Opin Urol 2006, 16:123-31.
6. Nelson WG, Yegnasubramanian S, Agoston AT. Abnormal DNA methylation, epigenetics, and prostate cancer. Front Biosci 2007, 12:4254-66.
7. Duffy M, McGowan P, Gallagher W. Cancer invasion and metastasis: changing views. J Pathol 2008, 214:283-93.
8. Richter E, Srivastava S, Dobi A. Androgen receptor and prostate cancer. Prostate Cancer Prostatic Dis 2007, 10:114-8.
9. Revelos K, Petraki C, Scorilas A. Correlation of androgen receptor status, neuroendocrine differentiation and angiogenesis with time-to-biochemical failure after radical prostatectomy in clinically localized prostate cancer. Anticancer Res 2007, 27:3651-60.
10. McVary KT. BPH: epidemiology and comorbidities. Am J Manag Care 2006, 12:S122-8.
11. Bradford TJ, Tomlins SA, Wang X, Chinnaiyan AM. Molecular markers of prostate cancer. Urol Oncol 2006, 24:538-51.
12. Reynolds MA, Kastury K, Groskopf J, Schalken JA, Rittenhouse H. Molecular markers for prostate cancer. Cancer Lett 2007, 249:5-13.
13. Gregorakis AK, Malovrouvas D, Stefanakis S, Petraki K, Scorilas A. Free/Total PSA (F/T ratio) kinetics in patients with clinically localized prostate cancer undergoing radical prostatectomy. Clin Chim Acta 2005, 357:196-201.
14. Borgono CA, Diamandis EP. The emerging roles of human tissue kallikreins in cancer. Nat Rev Cancer 2004, 4:876-90.
15. Scorilas A, Yu H, Soosaipillai AR, Gregorakis AK, Diamandis EP. Comparison of the percent free prostate-specific antigen levels in the serum of healthy men and in men with recurrent prostate cancer after radical prostatectomy. Clin Chim Acta 2000, 292:127-38.
16. Borgono CA, Michael IP, Diamandis EP. Human tissue kallikreins: physiologic roles and applications in cancer. Mol Cancer Res 2004, 2:257-80.
17. Diamandis EP, Yousef GM. Human tissue kallikreins: a family of new cancer biomarkers. Clin Chem 2002, 48:1198-205.
18. Kurlender L, Borgono C, Michael IP. A survey of alternative transcripts of human tissue kallikrein genes. Biochim Biophys Acta 2005, 1755:1-14.
19. Yousef GM, Chang A, Scorilas A, Diamandis EP. Genomic organization of the human kallikrein gene family on chromosome 19q13.3-q13.4. Biochem Biophys Res Commun 2000, 276:125-33.
20. Emami N, Diamandis EP. Human tissue kallikreins: a road under construction. Clin Chim Acta 2007, 381:78-84.
21. Petraki CD, Papanastasiou PA, Karavana VN, Diamandis EP. Cellular distribution of human tissue kallikreins: immunohistochemical localization. Biol Chem 2006, 387:653-63.
22. Shaw JL, Diamandis EP. Distribution of 15 human kallikreins in tissues and biological fluids. Clin Chem 2007, 53:1423-32.
23. Oikonomopoulou K, Scorilas A, Michael IP. Kallikreins as markers of disseminated tumour cells in ovarian cancer - a pilot study. Tumour Biol 2006, 27:104-14.
24. Yousef GM, Diamandis EP. Human tissue kallikreins: a new enzymatic cascade pathway? Biol Chem 2002, 383:1045-57.
25. Lopez-Otin C, Matrisian LM. Emerging roles of proteases in tumour suppression. Nat Rev Cancer 2007, 7:800-8.
26. Paliouras M, Borgono C, Diamandis EP. Human tissue kallikreins: the cancer biomarker family. Cancer Lett 2007, 249:61-79.
27. Obiezu CV, Diamandis EP. Human tissue kallikrein gene family: applications in cancer. Cancer Lett 2005, 224:1-22.
28. Stephan C, Yousef GM, Scorilas A. Quantitative analysis of kallikrein 15 gene expression in prostate tissue. J Urol 2003, 169:361-4.
29. Yousef GM, Stephan C, Scorilas A. Differential expression of the human kallikrein gene 14 (KLK14) in normal and cancerous prostatic tissues. Prostate 2003, 56:287-92.
30. Obiezu CV, Soosaipillai A, Jung K. Detection of human kallikrein 4 in healthy and cancerous prostatic tissues by immunofluorometry and immunohistochemistry. Clin Chem 2002, 48:1232-40.
31. Scorilas A, Gregorakis AK. mRNA expression analysis of human kallikrein 11 (KLK11) may be useful in the discrimination of benign prostatic hyperplasia from prostate cancer after needle prostate biopsy. Biol Chem 2006, 387:789-93.
32. Nakamura T, Stephan C, Scorilas A, Yousef GM, Jung K, Diamandis EP. Quantitative analysis of hippostasin/KLK11 gene expression in cancerous and noncancerous prostatic tissues. Urology 2003, 61:1042-6.
33. Yousef GM, Scorilas A, Jung K, Ashworth LK, Diamandis EP. Molecular cloning of the human kallikrein 15 gene (KLK15). Up-regulation in prostate cancer. J Biol Chem 2001, 276:53-61.
34. Shaw JL, Grass L, Sotiropoulou G, Diamandis EP. Development of an immunofluorometric assay for human kallikrein 15 (KLK15) and identification of KLK15 in tissues and biological fluids. Clin Biochem 2007, 40:104-10.
35. Yousef GM, Scorilas A, Katsaros D. Prognostic value of the human kallikrein gene 15 expression in ovarian cancer. J Clin Oncol 2003, 21:3119-26.
36. Yousef GM, Scorilas A, Magklara A. The androgen-regulated gene human kallikrein 15 (KLK15) is an independent and favourable prognostic marker for breast cancer. Br J Cancer 2002, 87:1294-300.
37. Ohl F, Jung M, Xu C. Gene expression studies in prostate cancer tissue: which reference gene should be selected for normalization? J Mol Med 2005, 83:1014-24.